Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 1/2018

02.11.2017 | Original Article

Impairment of astrocytic glutaminolysis in glutaric aciduria type I

verfasst von: Shoko Komatsuzaki, Raga Deepthi Ediga, Jürgen G. Okun, Stefan Kölker, Sven W. Sauer

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Glutaric aciduria type I is a rare, autosomal recessive, inherited defect of glutaryl-CoA dehydrogenase. Deficiency of this protein in L-lysine degradation leads to the characteristic accumulation of nontoxic glutarylcarnitine and neurotoxic glutaric acid (GA), glutaryl-CoA, and 3-hydroxyglutaric acid. Untreated patients develop bilateral lesions of basal ganglia resulting in a complex movement disorder with predominant dystonia in infancy and early childhood. The current pathomechanistic concept strongly focuses on imbalanced neuronal energy metabolism due to accumulating metabolites, whereas little is known about the pathomechanistic role of astrocytes, which are thought to be in constant metabolic crosstalk with neurons. We found that glutaric acid (GA) causes astrocytic cell death under starvation cell culture conditions, i.e. low glucose, without glutamine and fetal calf serum. Glutamine completely abolished GA-induced toxicity, suggesting involvement of glutaminolysis. Increasing dependence on glutaminolysis by chemical induction of hypoxia signaling-potentiated GA-induced toxicity. We further show that GA disturbs glutamine degradation by specifically inhibiting glutamate dehydrogenase. Summarizing our study shows that pathologically relevant concentrations of GA block an important step in the metabolic crosstalk between neurons and astrocytes, ultimately leading to astrocytic cell death.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Archibald RM (1944) Preparation and assay of glutaminase for glutamine determinations. J Biol Chem 154:657–667 Archibald RM (1944) Preparation and assay of glutaminase for glutamine determinations. J Biol Chem 154:657–667
Zurück zum Zitat Basinger AA, Booker JK, Frazier DM, Koeberl DD, Sullivan JA, Muenzer J (2006) Glutaric acidemia type 1 in patients of Lumbee heritage from North Carolina. Mol Genet Metab 88:90–92CrossRef Basinger AA, Booker JK, Frazier DM, Koeberl DD, Sullivan JA, Muenzer J (2006) Glutaric acidemia type 1 in patients of Lumbee heritage from North Carolina. Mol Genet Metab 88:90–92CrossRef
Zurück zum Zitat Boy N, Mühlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, Dixon M, Fleissner S, Greenberg CR, Harting I (2017) Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis 40:75–101CrossRef Boy N, Mühlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, Dixon M, Fleissner S, Greenberg CR, Harting I (2017) Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis 40:75–101CrossRef
Zurück zum Zitat Braissant O, Jafari P, Remacle N, Cudré-Cung H-P, Pereira SDV, Ballhausen D (2017) Immunolocalization of glutaryl-CoA dehydrogenase (GCDH) in adult and embryonic rat brain and peripheral tissues. Neuroscience 343:355–363CrossRef Braissant O, Jafari P, Remacle N, Cudré-Cung H-P, Pereira SDV, Ballhausen D (2017) Immunolocalization of glutaryl-CoA dehydrogenase (GCDH) in adult and embryonic rat brain and peripheral tissues. Neuroscience 343:355–363CrossRef
Zurück zum Zitat Caughey WS, Smiley JD, Hellerman L (1957) l-Glutamic acid dehydrogenase: structural requirements for substrate competition: effect of thyroxine. J Biol Chem 224:591–607PubMed Caughey WS, Smiley JD, Hellerman L (1957) l-Glutamic acid dehydrogenase: structural requirements for substrate competition: effect of thyroxine. J Biol Chem 224:591–607PubMed
Zurück zum Zitat Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, Leung IK, Li XS, Woon EC, Yang M, McDonough MA, King ON, Clifton IJ, Klose RJ, Claridge TD, Ratcliffe PJ, Schofield CJ, Kawamura A (2011) The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12:463–469CrossRef Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, Leung IK, Li XS, Woon EC, Yang M, McDonough MA, King ON, Clifton IJ, Klose RJ, Claridge TD, Ratcliffe PJ, Schofield CJ, Kawamura A (2011) The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12:463–469CrossRef
Zurück zum Zitat Funk CB, Prasad AN, Frosk P, Sauer S, Kölker S, Greenberg CR, Del Bigio MR (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722CrossRef Funk CB, Prasad AN, Frosk P, Sauer S, Kölker S, Greenberg CR, Del Bigio MR (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128:711–722CrossRef
Zurück zum Zitat Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst R, Lindmark T, Mabondzo A, Nilsson J, Raub T (2005) In vitro models for the blood–brain barrier. Toxicol In Vitro 19:299–334CrossRef Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst R, Lindmark T, Mabondzo A, Nilsson J, Raub T (2005) In vitro models for the blood–brain barrier. Toxicol In Vitro 19:299–334CrossRef
Zurück zum Zitat Greenberg C, Prasad A, Dilling L, Thompson J, Haworth J, Martin B, Wood-Steiman P, Seargeant L, Seifert B, Booth F (2002) Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75:70–78CrossRef Greenberg C, Prasad A, Dilling L, Thompson J, Haworth J, Martin B, Wood-Steiman P, Seargeant L, Seifert B, Booth F (2002) Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75:70–78CrossRef
Zurück zum Zitat Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, Troncoso M, Mühlhausen C, Zschocke J, Boy NP (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782CrossRef Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, Troncoso M, Mühlhausen C, Zschocke J, Boy NP (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132:1764–1782CrossRef
Zurück zum Zitat Heringer J, Boy S, Ensenauer R, Assmann B, Zschocke J, Harting I, Lücke T, Maier EM, Mühlhausen C, Haege G (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752CrossRef Heringer J, Boy S, Ensenauer R, Assmann B, Zschocke J, Harting I, Lücke T, Maier EM, Mühlhausen C, Haege G (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68:743–752CrossRef
Zurück zum Zitat Jafari P, Braissant O, Zavadakova P, Henry H, Bonafe L, Ballhausen D (2013) Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I. PLoS One 8:e53735CrossRef Jafari P, Braissant O, Zavadakova P, Henry H, Bonafe L, Ballhausen D (2013) Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I. PLoS One 8:e53735CrossRef
Zurück zum Zitat Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55:7–12CrossRef Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55:7–12CrossRef
Zurück zum Zitat Kölker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM, Ribes A, Kalkanoglu HS, Lund AM, Merinero B, Wajner M, Troncoso M, Williams M, Walter JH, Campistol J, Marti-Herrero M, Caswill M, Burlina AB, Lagler F, Maier EM, Schwahn B, Tokatli A, Dursun A, Coskun T, Chalmers RA, Koeller DM, Zschocke J, Christensen E, Burgard P, Hoffmann GF (2006a) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRef Kölker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM, Ribes A, Kalkanoglu HS, Lund AM, Merinero B, Wajner M, Troncoso M, Williams M, Walter JH, Campistol J, Marti-Herrero M, Caswill M, Burlina AB, Lagler F, Maier EM, Schwahn B, Tokatli A, Dursun A, Coskun T, Chalmers RA, Koeller DM, Zschocke J, Christensen E, Burgard P, Hoffmann GF (2006a) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840–847CrossRef
Zurück zum Zitat Kölker S, Sauer S, Surtees R, Leonard J (2006b) The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. J Inherit Metab Dis 29:701–704CrossRef Kölker S, Sauer S, Surtees R, Leonard J (2006b) The aetiology of neurological complications of organic acidaemias—a role for the blood–brain barrier. J Inherit Metab Dis 29:701–704CrossRef
Zurück zum Zitat Kölker S, Garbade SF, Boy N, Maier EM, Meissner T, Muhlhausen C, Hennermann JB, Lucke T, Haberle J, Baumkotter J, Haller W, Muller E, Zschocke J, Burgard P, Hoffmann GF (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363CrossRef Kölker S, Garbade SF, Boy N, Maier EM, Meissner T, Muhlhausen C, Hennermann JB, Lucke T, Haberle J, Baumkotter J, Haller W, Muller E, Zschocke J, Burgard P, Hoffmann GF (2007) Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res 62:357–363CrossRef
Zurück zum Zitat Kölker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, Burlina AP, Dixon M, Duran M, Cazorla AG (2011) Diagnosis and management of glutaric aciduria type I–revised recommendations. J Inherit Metab Dis 34:677–694CrossRef Kölker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, Burlina AP, Dixon M, Duran M, Cazorla AG (2011) Diagnosis and management of glutaric aciduria type I–revised recommendations. J Inherit Metab Dis 34:677–694CrossRef
Zurück zum Zitat Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C (2012) Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis 35:571–587CrossRef Kranendijk M, Struys EA, Salomons GS, Van der Knaap MS, Jakobs C (2012) Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis 35:571–587CrossRef
Zurück zum Zitat Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Muhlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. J Biol Chem 286:17777–17784CrossRef Lamp J, Keyser B, Koeller DM, Ullrich K, Braulke T, Muhlhausen C (2011) Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. J Biol Chem 286:17777–17784CrossRef
Zurück zum Zitat Magistretti PJ, Allaman I (2015) A cellular perspective on brain energy metabolism and functional imaging. Neuron 86:883–901CrossRef Magistretti PJ, Allaman I (2015) A cellular perspective on brain energy metabolism and functional imaging. Neuron 86:883–901CrossRef
Zurück zum Zitat McKenna MC, Stridh MH, McNair LF, Sonnewald U, Waagepetersen HS, Schousboe A (2016) Glutamate oxidation in astrocytes: Roles of glutamate dehydrogenase and aminotransferases. J Neurosci Res 94:1561–1571CrossRef McKenna MC, Stridh MH, McNair LF, Sonnewald U, Waagepetersen HS, Schousboe A (2016) Glutamate oxidation in astrocytes: Roles of glutamate dehydrogenase and aminotransferases. J Neurosci Res 94:1561–1571CrossRef
Zurück zum Zitat Nakazawa MS, Keith B, Simon MC (2016) Oxygen availability and metabolic adaptations. Nat Rev Cancer 16:663–673CrossRef Nakazawa MS, Keith B, Simon MC (2016) Oxygen availability and metabolic adaptations. Nat Rev Cancer 16:663–673CrossRef
Zurück zum Zitat Naughten E, Mayne P, Monavari A, Goodman S, Sulaiman G, Croke D (2004) Glutaric aciduria type I: outcome in the Republic of Ireland. J Inherit Metab Dis 27:917–920CrossRef Naughten E, Mayne P, Monavari A, Goodman S, Sulaiman G, Croke D (2004) Glutaric aciduria type I: outcome in the Republic of Ireland. J Inherit Metab Dis 27:917–920CrossRef
Zurück zum Zitat Nissen JD, Lykke K, Bryk J, Stridh MH, Zaganas I, Skytt DM, Schousboe A, Bak LK, Enard W, Pääbo S (2016) Expression of the human isoform of glutamate dehydrogenase, hGDH2, augments TCA cycle capacity and oxidative metabolism of glutamate during glucose deprivation in astrocytes. Glia 65:474–488CrossRef Nissen JD, Lykke K, Bryk J, Stridh MH, Zaganas I, Skytt DM, Schousboe A, Bak LK, Enard W, Pääbo S (2016) Expression of the human isoform of glutamate dehydrogenase, hGDH2, augments TCA cycle capacity and oxidative metabolism of glutamate during glucose deprivation in astrocytes. Glia 65:474–488CrossRef
Zurück zum Zitat Nota B, Struys EA, Pop A, Jansen EE, Ojeda MRF, Kanhai WA, Kranendijk M, van Dooren SJ, Bevova MR, Sistermans EA (2013) Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2-and L-2-hydroxyglutaric aciduria. Am J Hum Genet 92:627–631CrossRef Nota B, Struys EA, Pop A, Jansen EE, Ojeda MRF, Kanhai WA, Kranendijk M, van Dooren SJ, Bevova MR, Sistermans EA (2013) Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2-and L-2-hydroxyglutaric aciduria. Am J Hum Genet 92:627–631CrossRef
Zurück zum Zitat Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510–522CrossRef Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510–522CrossRef
Zurück zum Zitat Olivera-Bravo S, Fernández A, Sarlabós MN, Rosillo JC, Casanova G, Jiménez M, Barbeito L (2011) Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I. PLoS One 6:e20831CrossRef Olivera-Bravo S, Fernández A, Sarlabós MN, Rosillo JC, Casanova G, Jiménez M, Barbeito L (2011) Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric acidemia-I. PLoS One 6:e20831CrossRef
Zurück zum Zitat Olivera-Bravo S, Ribeiro CA, Isasi E, Trías E, Leipnitz G, Díaz-Amarilla P, Woontner M, Beck C, Goodman SI, Souza D (2015) Striatal neuronal death mediated by astrocytes from the Gcdh−/− mouse model of glutaric acidemia type I. Hum Mol Genet 24:4504–4515CrossRef Olivera-Bravo S, Ribeiro CA, Isasi E, Trías E, Leipnitz G, Díaz-Amarilla P, Woontner M, Beck C, Goodman SI, Souza D (2015) Striatal neuronal death mediated by astrocytes from the Gcdh−/− mouse model of glutaric acidemia type I. Hum Mol Genet 24:4504–4515CrossRef
Zurück zum Zitat Olney J, Ho OL, Rhee V (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res 14:61–76CrossRef Olney J, Ho OL, Rhee V (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res 14:61–76CrossRef
Zurück zum Zitat Porciúncula LO, Emanuelli T, Tavares RG, Schwarzbold C, Frizzo ME, Souza DO, Wajner M (2004) Glutaric acid stimulates glutamate binding and astrocytic uptake and inhibits vesicular glutamate uptake in forebrain from young rats. Neurochem Int 45:1075–1086CrossRef Porciúncula LO, Emanuelli T, Tavares RG, Schwarzbold C, Frizzo ME, Souza DO, Wajner M (2004) Glutaric acid stimulates glutamate binding and astrocytic uptake and inhibits vesicular glutamate uptake in forebrain from young rats. Neurochem Int 45:1075–1086CrossRef
Zurück zum Zitat Rose NR, McDonough MA, King ON, Kawamura A, Schofield CJ (2011) Inhibition of 2-oxoglutarate dependent oxygenases. Chem Soc Rev 40:4364–4397CrossRef Rose NR, McDonough MA, King ON, Kawamura A, Schofield CJ (2011) Inhibition of 2-oxoglutarate dependent oxygenases. Chem Soc Rev 40:4364–4397CrossRef
Zurück zum Zitat Sauer SW, Okun JG, Schwab MA, Crnic LR, Hoffmann GF, Goodman SI, Koeller DM, Kölker S (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836CrossRef Sauer SW, Okun JG, Schwab MA, Crnic LR, Hoffmann GF, Goodman SI, Koeller DM, Kölker S (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836CrossRef
Zurück zum Zitat Sauer SW, Okun JG, Fricker G, Mahringer A, Müller I, Crnic LR, Mühlhausen C, Hoffmann GF, Hörster F, Goodman SI (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97:899–910CrossRef Sauer SW, Okun JG, Fricker G, Mahringer A, Müller I, Crnic LR, Mühlhausen C, Hoffmann GF, Hörster F, Goodman SI (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97:899–910CrossRef
Zurück zum Zitat Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170CrossRef Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, Kölker S (2011) Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 134:157–170CrossRef
Zurück zum Zitat Steenweg ME, Jakobs C, Errami A, van Dooren SJ, Adeva Bartolomé MT, Aerssens P, Augoustides-Savvapoulou P, Baric I, Baumann M, Bonafé L (2010) An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype–phenotype study. Hum Mutat 31:380–390CrossRef Steenweg ME, Jakobs C, Errami A, van Dooren SJ, Adeva Bartolomé MT, Aerssens P, Augoustides-Savvapoulou P, Baric I, Baumann M, Bonafé L (2010) An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype–phenotype study. Hum Mutat 31:380–390CrossRef
Zurück zum Zitat Stellmer F, Keyser B, Burckhardt BC, Koepsell H, Streichert T, Glatzel M, Jabs S, Thiem J, Herdering W, Koeller DM, Goodman SI, Lukacs Z, Ullrich K, Burckhardt G, Braulke T, Muhlhausen C (2007) 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. J Mol Med 85:763–770CrossRef Stellmer F, Keyser B, Burckhardt BC, Koepsell H, Streichert T, Glatzel M, Jabs S, Thiem J, Herdering W, Koeller DM, Goodman SI, Lukacs Z, Ullrich K, Burckhardt G, Braulke T, Muhlhausen C (2007) 3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3. J Mol Med 85:763–770CrossRef
Zurück zum Zitat Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 121C:38–52CrossRef Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet 121C:38–52CrossRef
Zurück zum Zitat Strauss KA, Lazovic J, Wintermark M, Morton DH (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920CrossRef Strauss KA, Lazovic J, Wintermark M, Morton DH (2007) Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 130:1905–1920CrossRef
Zurück zum Zitat Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76–92CrossRef Strauss KA, Donnelly P, Wintermark M (2010) Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 133:76–92CrossRef
Zurück zum Zitat Strauss KA, Brumbaugh J, Duffy A, Wardley B, Robinson D, Hendrickson C, Tortorelli S, Moser AB, Puffenberger EG, Rider NL, Morton DH (2011) Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab 104:93–106CrossRef Strauss KA, Brumbaugh J, Duffy A, Wardley B, Robinson D, Hendrickson C, Tortorelli S, Moser AB, Puffenberger EG, Rider NL, Morton DH (2011) Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Mol Genet Metab 104:93–106CrossRef
Zurück zum Zitat van der Watt G, Owen EP, Berman P, Meldau S, Watermeyer N, Olpin SE, Manning NJ, Baumgarten I, Leisegang F, Henderson H (2010) Glutaric aciduria type 1 in South Africa-high incidence of glutaryl-CoA dehydrogenase deficiency in black South Africans. Mol Genet Metab 101:178–182CrossRef van der Watt G, Owen EP, Berman P, Meldau S, Watermeyer N, Olpin SE, Manning NJ, Baumgarten I, Leisegang F, Henderson H (2010) Glutaric aciduria type 1 in South Africa-high incidence of glutaryl-CoA dehydrogenase deficiency in black South Africans. Mol Genet Metab 101:178–182CrossRef
Zurück zum Zitat Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, Liu LX, Jiang WQ, Liu J, Zhang JY, Wang B, Frye S, Zhang Y, Xu YH, Lei QY, Guan KL, Zhao SM, Xiong Y (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1):17–30CrossRef Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, Liu LX, Jiang WQ, Liu J, Zhang JY, Wang B, Frye S, Zhang Y, Xu YH, Lei QY, Guan KL, Zhao SM, Xiong Y (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1):17–30CrossRef
Zurück zum Zitat Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773CrossRef Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773CrossRef
Zurück zum Zitat Yodoya E, Wada M, Shimada A, Katsukawa H, Okada N, Yamamoto A, Ganapathy V, Fujita T (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J Neurochem 97:162–173CrossRef Yodoya E, Wada M, Shimada A, Katsukawa H, Okada N, Yamamoto A, Ganapathy V, Fujita T (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J Neurochem 97:162–173CrossRef
Zurück zum Zitat Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003) Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J Biol Chem 278:15911–15916CrossRef Yuan Y, Hilliard G, Ferguson T, Millhorn DE (2003) Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J Biol Chem 278:15911–15916CrossRef
Zurück zum Zitat Zinnanti WJ, Lazovic J, Housman C, LaNoue K, O’Callaghan JP, Simpson I, Woontner M, Goodman SI, Connor JR, Jacobs RE (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270CrossRef Zinnanti WJ, Lazovic J, Housman C, LaNoue K, O’Callaghan JP, Simpson I, Woontner M, Goodman SI, Connor JR, Jacobs RE (2007) Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. J Clin Invest 117:3258–3270CrossRef
Metadaten
Titel
Impairment of astrocytic glutaminolysis in glutaric aciduria type I
verfasst von
Shoko Komatsuzaki
Raga Deepthi Ediga
Jürgen G. Okun
Stefan Kölker
Sven W. Sauer
Publikationsdatum
02.11.2017
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 1/2018
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0096-5

Weitere Artikel der Ausgabe 1/2018

Journal of Inherited Metabolic Disease 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.